Read key research highlights that will be presented at the 2018 ASCO Annual Meeting, including monitoring symptoms with technology, screening and genomic testing for lung cancer, and new treatment regimens for breast cancer and T-cell leukemia and lymphoma.
The 2018 Clinical Cancer Advances report of the American Society of Clinical Oncology has crowned an adoptive cell immunotherapy as its Advance of the Year. What is this innovative cancer treatment? What are the risks and benefits?
In this month’s From the Editor’s Desk, Dr. Schapira reflects on the mutual trust and respect that can develop between oncologists and their patients.
Research Round Up Podcast: Managing Side Effects, Breast Cancer, Chronic Myeloid Leukemia, and Myeloma
Cancer.Net Associate Editors discuss exciting new cancer research in the final Research Round Up podcast of the summer.
Michael E. Williams, MD, ScM discusses highlights from the recent American Society of Hematology Annual Meeting. Listen in to hear what’s new in treatment for blood cancers.
This year, President Obama has focused attention on treatments and tools that help doctors tailor medical care for individual patients. Research presented at the 2015 ASCO Annual Meeting shows how targeted therapies can be used to improve the care of people with a number of different types of blood cancer.
Hearing the word cancer is one of people’s biggest fears. In this guest post, Dr. Rick Boulay challenges everything you thought you knew about cancer and shares how he found hope after his wife was diagnosed with leukemia.
Recognizing the dramatic advances in the treatment of chronic lymphocytic leukemia (CLL), ASCO named the approval of four new drugs for this disease in 2014 as its first “Advance of the Year.”
Learn more about four studies that show the potential of new targeted therapies for advanced ovarian, lung, and thyroid cancers and chronic lymphocytic leukemia.